Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

5.50USD
21 Mar 2019
Change (% chg)

-- (--)
Prev Close
$5.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,933
52-wk High
$10.00
52-wk Low
$4.11

Chart for

About

Arcturus Therapeutics Ltd is a ribonucleic acid (RNA) medicines company. The Company’s technology platform includes Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) and Unlocked Nucleomonomer Agent (UNA). The Company’s diverse pipeline of RNA therapeutics includes programs pursuing rare diseases, hepatitis B,... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $28.94
Shares Outstanding(Mil.): 27.56
Dividend: --
Yield (%): --

Financials

  ARCT.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -0.76 -- --
ROI: -41.68 8.89 13.82
ROE: -41.68 10.00 15.25

Earnings vs. Estimates